What is Withings?
Established in 2008 and headquartered in Issy-les-Moulineaux, France, Withings is a global electronics company specializing in connected health devices. The company designs and distributes a range of innovative products aimed at monitoring health and wellness, including smart scales, watches, blood pressure monitors, and sleep trackers. Withings focuses on providing users with actionable health insights through user-friendly technology, bridging the gap between personal health management and medical-grade data. Their commitment to design and user experience has positioned them as a key player in the burgeoning digital health market.
How much funding has Withings raised?
Withings has raised a total of $93.8M across 3 funding rounds:
Series A
$3.8M
Unspecified
$30M
Series B
$60M
Series A (2010): $3.8M with participation from Ventech Solutions
Unspecified (2013): $30M led by Ventech Solutions, Bpifrance, Idinvest Partners, and 360 Capital Partners
Series B (2020): $60M supported by Gilde Healthcare, Idinvest Partners, ODDO BHF Private Equity, BNP Paribas Développement, Bpifrance, and Adelie Capital
Key Investors in Withings
Gilde Healthcare
Gilde Healthcare is a specialized healthcare investment firm managing over €1.4 billion across three fund strategies, focusing on businesses that enable better care at lower costs and address planetary challenges. They invest in healthtech, therapeutics, and climate-related companies.
Idinvest Partners
Idinvest Partners is a mid-market private equity company that finances and supports entrepreneurs at different stages of their business development. Founded in 1997, it is headquartered in Paris, France.
Bpifrance
Bpifrance finances companies at every stage of their development with credit, guarantees, and equity, supporting innovation, international expansion, and export activities for startups, SMEs, and mid-cap companies.
What's next for Withings?
The recent major strategic investment of $60M signals a new phase of growth and development for Withings. This capital infusion is expected to accelerate product innovation, expand market reach, and potentially explore new strategic partnerships. Given the company's focus on connected health devices and its established presence, this backing will likely enable Withings to further enhance its ecosystem of health monitoring tools and solidify its competitive edge in the rapidly evolving digital health landscape. The company's trajectory suggests a continued emphasis on leveraging technology for proactive health management.
See full Withings company page
